PROFESSIONAL DIVERSITY NETWO (IPDN)

US74312Y3018 - Common Stock

1.28  -0.42 (-24.71%)

After market: 1.2016 -0.08 (-6.13%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to IPDN. IPDN was compared to 81 industry peers in the Professional Services industry. IPDN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. IPDN does not seem to be growing, but still is valued expensively.



1

1. Profitability

1.1 Basic Checks

In the past year IPDN has reported negative net income.
IPDN had a negative operating cash flow in the past year.
IPDN had negative earnings in each of the past 5 years.
IPDN had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -68.12%, IPDN is doing worse than 92.50% of the companies in the same industry.
IPDN's Return On Equity of -141.39% is on the low side compared to the rest of the industry. IPDN is outperformed by 90.00% of its industry peers.
Industry RankSector Rank
ROA -68.12%
ROE -141.39%
ROIC N/A
ROA(3y)-45.63%
ROA(5y)-49.07%
ROE(3y)-114.11%
ROE(5y)-124.55%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a decent Gross Margin value of 55.06%, IPDN is doing good in the industry, outperforming 66.25% of the companies in the same industry.
In the last couple of years the Gross Margin of IPDN has declined.
The Profit Margin and Operating Margin are not available for IPDN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.54%
GM growth 5Y-8.72%

4

2. Health

2.1 Basic Checks

IPDN does not have a ROIC to compare to the WACC, probably because it is not profitable.
IPDN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, IPDN has more shares outstanding
IPDN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of -19.91, we must say that IPDN is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -19.91, IPDN is doing worse than 97.50% of the companies in the same industry.
IPDN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -19.91
ROIC/WACCN/A
WACC9.22%

2.3 Liquidity

IPDN has a Current Ratio of 0.68. This is a bad value and indicates that IPDN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.68, IPDN is doing worse than 90.00% of the companies in the same industry.
IPDN has a Quick Ratio of 0.68. This is a bad value and indicates that IPDN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.68, IPDN is doing worse than 90.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.68
Quick Ratio 0.68

1

3. Growth

3.1 Past

IPDN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -37.87%.
Looking at the last year, IPDN shows a decrease in Revenue. The Revenue has decreased by -7.31% in the last year.
Measured over the past years, IPDN shows a small growth in Revenue. The Revenue has been growing by 0.21% on average per year.
EPS 1Y (TTM)-37.87%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q61.53%
Revenue 1Y (TTM)-7.31%
Revenue growth 3Y19.96%
Revenue growth 5Y0.21%
Revenue growth Q2Q-2.86%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

IPDN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

IPDN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PROFESSIONAL DIVERSITY NETWO

NASDAQ:IPDN (5/3/2024, 5:13:36 PM)

After market: 1.2016 -0.08 (-6.13%)

1.28

-0.42 (-24.71%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap14.66M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -68.12%
ROE -141.39%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 55.06%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.68
Quick Ratio 0.68
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-37.87%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-7.31%
Revenue growth 3Y19.96%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y